ISS and Glass Lewis recommend Dalradian shareholders vote

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
39
ISS and Glass Lewis recommend Dalradian shareholders vote FOR the arrangement

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Dalradian Resources Inc. (TSX: DNA/AIM: DALR) (“Dalradian” or the “Company”) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co., LLC (“Glass Lewis”), two leading independent proxy advisory firms, have both recommended that Dalradian shareholders vote FOR the previously announced transaction (the “Transaction”) with certain affiliates of Orion Mine Finance (“Orion”).

The Transaction provides for the acquisition by Orion of the issued and outstanding common shares of the Company (“Dalradian Shares”) by way of a statutory plan of arrangement under the Business Corporations Act (Ontario), other than Dalradian Shares owned by Orion or its affiliates, and by certain members of Dalradian’s senior management team, Sean Roosen and Osisko Gold Royalties Ltd (collectively, the “Remaining Shareholders”). Each Dalradian shareholder (other than the Remaining Shareholders) will receive cash consideration of C$1.47 for each Dalradian Share held.

The special meeting of Dalradian’s shareholders to consider the Transaction will be held on August 31, 2018 at the offices of Cassels Brock & Blackwell LLP, 2100 Scotia Plaza, 40 King Street West, Toronto, Ontario, M5H 3C2, at 10:00 am (Toronto time). The record date for determining the Dalradian shareholders entitled to receive notice of and vote at the Meeting was July 16, 2018.

Copies of the management information circular and related documents in respect of the Transaction were mailed to Dalradian’s shareholders and are available on Dalradian’s profile on SEDAR (www.sedar.com) and Dalradian’s website (www.dalradian.com/investor-centre/Shareholder-Meetings). Shareholders are encouraged to read the management information circular in detail.

Your vote is important regardless of the number of Dalradian Shares you own. Shareholders who have questions regarding the Transaction or who require assistance with voting may contact our proxy solicitation agent, D.F. King & Co., by telephone toll-free in North America at 1.800.926.7043 (1.212.771.1133 by collect call) or by email at inquiries@dfking.com .

About Dalradian Resources Inc.

Dalradian Resources Inc. is a mineral exploration and development company that is focused on advancing its high-grade Curraghinalt Gold Project located in Northern Ireland, United Kingdom. The Curraghinalt Project is in permitting, with various technical studies ongoing to build on the positive feasibility study released in January 2017.

For more information:

Marla Gale Vice President Communications +1 416 583 5600 investor@dalradian.com

Grant Thornton UK LLP (Nominated Adviser) Philip Secrett / Richard Tonthat / Harrison Clark +44 (0)20 7383 5100

Numis Securities Limited (Broker)  John Prior / James Black / Paul Gillam           +44 (0)20 7260 1000

FORWARD LOOKING STATEMENTS

This press release contains “forward-looking information” which may include, but is not limited to, statements with respect to anticipated meeting date and timing for completion of the Transaction and delisting from both the TSX and AIM, the delivery of an updated feasibility study and an updated technical report, future financial or operating performance of the Company and its subsidiaries and its mineral project, the future price of metals, test work and confirming results from work performed to date, the estimation of mineral resources and mineral reserves, the realization of mineral resource and mineral reserve estimates, the timing and amount of estimated future production, costs of production, capital, operating and exploration expenditures, costs and timing of the development of new deposits, costs and timing of future exploration, requirements for additional capital, government regulation of mining operations, environmental risks, reclamation expenses, title disputes or claims, limitations of insurance coverage, the timing and possible outcome of pending regulatory matters and the realization of the expected production, economics and mine life of the Curraghinalt gold deposit.

Often, but not always, forward-looking statements can be identified by the use of words and phrases such as “plans,” “expects,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates,” or “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may,” “could,” “would,” “might” or “will” be taken, occur or be achieved.

Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and are based on various assumptions that management believes are reasonable, such as the receipt of all shareholder and regulatory approvals, no undue delays with respect to the Transaction, effects of general economic conditions, changing foreign exchange rates and actions by government authorities, continued political stability in Northern Ireland, that permits required for Dalradian’s operations will be obtained in a timely basis in order to permit Dalradian to proceed on schedule with its planned exploration and mine development, construction and production programs, that a permitting application for mine construction will be approved, that skilled personnel and contractors will be available as Dalradian’s operations commence and continue to grow towards production and mining operations, that the price of gold will be at levels that render the Dalradian’s mineral project economic, and that the necessary capital will be available to finance Dalradian’s operations and realize on mineral resource and mineral reserve estimates and current mine plans.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Dalradian to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the risk that the required Dalradian shareholder approval or necessary court approvals may not be obtained in connection with the Transaction, uncertainties associated with negotiations, misjudgments in the course of preparing forward-looking information, the Transaction may not close when planned or at all or on the terms and conditions set forth in the Arrangement Agreement, the benefits expected from the Transaction not being realized, risks related to the integration of acquisitions, general business, economic, competitive, political and social uncertainties; legal challenges to permits or permitting applications; the actual results of current and future exploration activities; the actual results of reclamation activities; conclusions of economic evaluations; meeting various expected cost estimates; changes in project parameters and/or economic assessments as plans continue to be refined; future prices of metals; possible variations of mineral grade or recovery rates; the risk that actual costs may exceed estimated costs; failure of plant, equipment or processes to operate as anticipated; accidents, labour disputes and other risks of the mining industry; political instability; delays in obtaining governmental approvals or financing or in the completion of development or construction activities, as well as those factors discussed in the section entitled “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2017 dated March 15, 2018.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this press release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results, except as may be required by applicable securities laws. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IBM's Sports Tech Challenge Crowns AI Innovator LivXP

Updated Category News Views 18

Pioneering AI for Fan Engagement The big leagues of sports tech are buzzing, as IBM has just announced LivXP as the standout winner of their Sports Tech Startup Prize Challenge at the dynamic Web Summit Lisbon 2026. If there's one thing to remember, it's that this isn't just any accolade. This is a nod from IBM—an institution that's rubbed elbows with the giants of...

Continue Reading
Skilled Nursing: The Backbone of Comprehensive Care

Updated Category News Views 17

Crucial Crossroads: Hospital to Home Some stories don't come with ticker symbols or stock rises. Sometimes, we're sifting through what really matters—like Terry Esterline's rundown on skilled nursing and rehab services in Hillsdale, Michigan. This isn't about making a quick buck, it's about what helps people rebuild after a hospital stay. The Nuts and Bolts of Skilled...

Continue Reading
Nauticus Schedules 2026 Q3 Earnings Call; Key Insights Await

Updated Category News Views 100

Word on the street is that Nauticus Robotics is gearing up to dish out their third quarter earnings on November 17, 2026. If you're eyeballing the stock, NASDAQ:KITT, this might be your show. Autonomy in the subsea world isn't just about flashy tech—it's about getting investors to buy into the vision. These folks are turning waves into action with robots that perform...

Continue Reading
HLTH 2026: AI's Role in Couples Therapy Unveiled

Updated Category News Views 14

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Continue Reading
DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 266

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Baidu Faces Securities Suit Deadline This Week

Updated Category News Views 74

Deadline Looms Large for Baidu Investors Well, here we are again, dealing with another securities class action. If you've got your money parked in Baidu (NASDAQ:BIDU), the clock is ticking, and it's time to pay attention. November 13, 2026, is creeping up fast, and that could be a serious point of no return. What's the Buzz About? Faruqi & Faruqi, LLP, a heavyweight in...

Continue Reading
FIS Under Investigation: Legal Woes Hit Shareholders

Updated Category News Views 55

When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...

Continue Reading
Millrose Faces Class Action for Alleged Deception

Updated Category News Views 124

A Surprising Turn for Millrose Properties Nobody's grumbling over their coffee as much as Millrose Properties' investors these days. The company, traded under NYSE:MRP, is facing a securities class action lawsuit that'll make even the steeliest fund managers flinch. You see, this isn't just any lawsuit—it's a slap in the face of those who thought they were backing a...

Continue Reading
Frasle Mobility's Resilience Despite Market Woes in 3Q26

Updated Category News Views 125

Economic Wrangling: What Happened? Here comes Frasle Mobility, standing tall against a tide trying to pull everyone under. Ending the third quarter of 2026, they dropped a modest net revenue of R$1.38 billion. A light dip of 1.9% year-over-year, but don't let that fool you. Amid the chaos, these folks managed to expand their gross margin and kept their financials...

Continue Reading
MY DR NOW Challenges 9-to-5 with New Clinics

Updated Category News Views 12

Revolutionizing Healthcare Access Latte in one hand and the other hand tapping your steering wheel, trying to squeeze in that elusive doctor’s appointment between work meetings. Sound familiar? Well, those days might just be numbered. MY DR NOW is shaking up the traditional 9-to-5 doctor’s office stereotype by opening two new clinics that’ll stand sentinel seven...

Continue Reading

Top 5 Most Recently Viewed Articles

Immunocore Unveils Promising Data for Brenetafusp in Ovarian Cancer

Updated Category News Views 129

Immunocore Takes Key Steps with Brenetafusp Immunocore, a biotechnology firm dedicated to creating innovative immunomodulating treatments, has revealed important findings from the Phase 1 trials of brenetafusp, an ImmTAC bispecific that targets PRAME in ovarian cancer patients who are resistant to platinum therapy. These results were shared at a notable medical...

Continue Reading
Santhera and Ikris Pharma Join Forces for AGAMREE® in India

Updated Category News Views 216

Santhera Partners with Ikris for AGAMREE® Distribution Pratteln, Switzerland – Santhera Pharmaceuticals (SIX: SANN) has recently formed a pivotal agreement with Ikris Pharma Network to distribute AGAMREE® (vamorolone) in India. This exclusive partnership is dedicated to providing a treatment option for Duchenne muscular dystrophy (DMD) in children four years and...

Continue Reading
Orchid Island Capital Highlights August Dividend and Portfolio Insights

Updated Category News Views 183

Orchid Island Capital Declares August Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC), a prominent player in the specialized finance sector, has declared a monthly cash dividend of $0.12 per common share for August. This dividend is scheduled for distribution on September 29, keeping with the company’s commitment to returning value to its shareholders. Dividend...

Continue Reading
Mercari Japan App Debuts in U.S.: A Shopping Shift

Updated Category News Views 15

A New Frontier for Cross-Border Shopping There's a fresh wind blowing for collectors and Japan enthusiasts in the U.S. as Mercari Japan rolls out a new standalone app on American soil. Designed to streamline the hunt for Japanese treasures, it’s a bold play to solidify Mercari’s position as a cross-border e-commerce powerhouse. Maybe they’ve seen the writing on the...

Continue Reading
Franklin Access Receives Financing for Groundbreaking Sigbeat Venture

Updated Category News Views 195

Franklin Access Secures New Funding for Innovative Sigbeat Joint Venture Franklin Access (NASDAQ: FKWL) is thrilled to announce that it has successfully secured funding for its strategic joint venture to develop cutting-edge 4G/5G modules and artificial intelligence (AI) solutions under the Sigbeat brand. This significant milestone marks a transformative step towards...

Continue Reading